Fig. 4: Overview of the SARS-CoV-2 vaccine development landscape. | Nature

Fig. 4: Overview of the SARS-CoV-2 vaccine development landscape.

From: SARS-CoV-2 vaccines in development

Fig. 4

The chart shows the distribution of candidates from different vaccine platforms over the different development phases. *The two vaccines that are currently licensed include one produced by CanSino, which is currently in use in the Chinese military, and the vaccine from Gamaleya Research Institute in Russia, which was licensed without a phase III trial.

Back to article page